Pacer Advisors, Inc. Meridian Bioscience Inc Transaction History

Pacer Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	BUY	$30.9 - $33.55 $447,710 - $486,105	14,489 Added 11.25%	143,325 $4.52 Million
Q2 2022 Aug 12, 2022	BUY	$23.75 - $31.69 $3.06 Million - $4.08 Million	128,836 New	128,836 $3.92 Million
Q2 2020 Jul 29, 2020	SELL	$7.84 - $23.29 $42,390 - $125,929	-5,407 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$5.57 - $11.5 $35,402 - $73,094	-6,356 Reduced 54.03%	5,407 $59,000
Q4 2019 Feb 10, 2020	SELL	$7.9 - $10.14 $23,470 - $30,125	-2,971 Reduced 20.16%	11,763 $115,000
Q3 2019 Oct 10, 2019	BUY	$9.17 - $12.01 $21,586 - $28,271	2,354 Added 19.01%	14,734 $140,000
Q2 2019 Aug 12, 2019	BUY	$10.88 - $17.6 $134,694 - $217,888	12,380 New	12,380 $147,000
Q1 2018 May 14, 2018	SELL	$13.8 - $16.2 $10,391 - $12,198	-753 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$13.55 - $15.8 $4,457 - $5,198	-329 Reduced 30.41%	753 $11,000
Q3 2017 Nov 08, 2017	BUY	$13.45 - $14.35 $14,552 - $15,526	1,082	1,082 $15,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.